PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer
Condition(s):Colorectal CancerLast Updated:June 29, 2020Recruiting
Hide Studies Not Open or Pending
Condition(s):Colorectal CancerLast Updated:June 29, 2020Recruiting
Condition(s):Patent Ductus ArteriosusLast Updated:April 13, 2020Recruiting
Condition(s):TuberculosisLast Updated:February 18, 2019Unknown status
Condition(s):Acute Myeloid LeukemiaLast Updated:February 17, 2017Withdrawn
Condition(s):Patent Ductus ArteriosusLast Updated:September 3, 2020Recruiting
Condition(s):Colorectal Cancer; Mismatch Repair-deficient (dMMR); Microsatellite Instability-high (MSI-H); Neoadjuvant TherapyLast Updated:June 2, 2020Recruiting
Condition(s):PainLast Updated:July 2, 2017Completed
Condition(s):Precancerous ConditionLast Updated:August 12, 2013Completed
Condition(s):Facial PainLast Updated:March 4, 2008Completed
Condition(s):Retinal HypoxiaLast Updated:August 19, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.